As your ally, argenx is working to better understand severe autoimmune diseases and help bring new treatment possibilities to the people who need them most.
Clinical research studies are an important part of that progress, and every person who chooses to participate plays a meaningful role in advancing research for all patients living with these conditions. This learning center was created to help you better understand clinical research, explore helpful resources, and feel more informed as you consider what may be right for you or someone you care about.
People choose to participate in clinical research for many different reasons. Learn more about the motivations and personal considerations that may help you decide whether participating in a clinical research study is right for you.
Participating in a clinical research study may involve study visits, health checks, questionnaires, or investigational study drugs. Learn more about what participation may involve, how your safety is monitored throughout a study, and the important role you may play in helping researchers better understand diseases and potential future therapies.
Considering a clinical research study is a personal decision and may come with many questions. You may find it helpful to talk with your doctor, loved ones, and the study team as you explore participation. Learn more about possible benefits and risks, time commitments, and important questions to consider.
Clinical research studies are research studies that help doctors and researchers learn whether new approaches to care are safe and effective, and in some cases to further test existing treatments.
Clinical research studies look at ways to prevent, identify, or treat disease. Clinical research studies can study:
The goal of clinical research studies is to determine if these treatment, prevention, and behavior approaches are safe and effective. Participation in a clinical research study may involve study visits, health assessments, questionnaires, or monitoring over time.
Clinical research studies follow strict safety guidelines, and participants can leave a study at any time.
The Emnergize study is evaluating an investigational study drug for adults living with chronic inflammatory demyelinating polyneuropathy (CIDP). Click below to learn more about this study.
The Emvigorate study is evaluating an investigational study drug for adults living with chronic inflammatory demyelinating polyneuropathy (CIDP). Click below to learn more about this study.
argenx sponsors clinical trials researching investigational therapies for people living with severe autoimmune diseases. Explore currently recruiting studies and learn more about clinical trial participation, eligibility requirements, and study locations.
